Federal contract award
75F40125F19005
BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APPLICATIONS FOR THE FDA'S CENTER FOR
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40123D00021 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $519.9K |
| Current contract value | $519.9K |
| Potential contract value / ceiling | $1.4M |
| Start date | Aug 4, 2025 |
| Current end date | Apr 9, 2027 |
| Potential end date | Apr 9, 2029 |
| Latest award activity | Mar 18, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 18, 2026 | P00002 | $351.8K | REVISE OP1, OP2, OP3 AND EXERCISE OP1. BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APP |
| Dec 10, 2025 | P00001 | $0 | NO COST TIME EXTENSION (ALL PERIODS). BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APP |
| Aug 4, 2025 | 0 | $168.0K | BASE PERIOD AND THREE (3) OPTION PERIODS, LABOR HOUR (LH) TYPE TASK ORDER TO PROCURE REGULATORY SUPPORT IN THE RESEARCH AND DOCUMENTATION OF DATA AND INFORMATION TO SUPPORT THE REVIEW OF ABBREVIATED NEW DRUG APPLICATIONS FOR THE FDA'S CENTER FOR |
Estimated positioning window
Apr 9, 2028 – Oct 9, 2028
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2029-04-09 (890 days from calculation)
- +15 points
- 173 historical awards in this buyer and category group
- +15 points
- 3 recorded award transactions
- +5 points
- Latest award action: 2026-03-18
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.